| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790161 | Urologic Oncology: Seminars and Original Investigations | 2018 | 10 Pages |
Abstract
The addition of adjuvant therapy provided no survival benefit but increased the rates of adverse events for locally advanced RCC patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yangyang M.Med, Songchao M.D., Zhankui M.D., Yinghui M.Med, Chaohui M.D., Jinjian M.D.,